Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial FibrillationDavid B. DeLurgio, Hugh Calkins, Karl J. Crossen et al.|Circulation Arrhythmia and Electrophysiology|2020Cited by 246
2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failureFaisal G. Bakaeen, Bruce L. Wilkoff, Eric J. Velazquez et al.|Journal of Thoracic and Cardiovascular Surgery|2021Cited by 105
The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue†John D. Puskas, Joseph E. Bavaria, Lars G. Svensson et al.|European Journal of Cardio-Thoracic Surgery|2017Cited by 89
Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissueDouglas R. Johnston, Craig R. Smith, Bartley P. Griffith et al.|Journal of Thoracic and Cardiovascular Surgery|2020Cited by 42
Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE TrialDavid B. DeLurgio, Jaswinder Gill, Christopher Blauth et al.|Heart Rhythm O2|2022Cited by 19